Greg Lazar, Ph.D.Co-Founder and Chief Technology Officer at Dualitas TherapeuticsSpeaker
Profile
Dr. Lazar is Co-Founder and Chief Technology Officer at Dualitas Therapeutics. Prior to joining Dualitas he led research groups at Xencor, Eli Lilly, and Genentech. He received his BS in Molecular & Cell Biology and Chemistry from Penn State, his PhD in Molecular & Cell Biology from the University of California, Berkeley, and was a postdoctoral fellow at the University of Cambridge, UK. Dr. Lazar is an expert in biotherapeutic engineering and drug discovery, and has developed technologies and molecules that have contributed to 3 approved drugs and over 10 candidates across Phase I-III clinical trials. He is an inventor of over 30 patents and has authored over 40 scientific publications in the fields of protein and antibody structure, design, engineering, and therapeutics.
Agenda Sessions
Antibody Architectures and Interfaces - Nature’s Guide to Biotherapeutic Engineering
, 10:30amView Session